Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Feasibility and stage at diagnosis for children with cancer: a pilot study on population-based data in a middle-income country using the Toronto childhood cancer stage guidelines.
Ecancermedicalscience
November 2024
Instituto Nacional de Câncer, Rio de Janeiro, RJ 20.230-240, Brazil.
Background: The aim was to conduct a pilot study in a middle-income country testing the use of the Toronto Childhood Cancer Staging System by Population-Based Cancer Registry (PBCR).
Methods: This study involved first the translation of the Australian pediatric cancer staging manual for 16 types of pediatric tumours. Four PBCRs from different regions of Brazil were selected for a pilot study.
JMIR Dermatology's 2023 Year in Review.
JMIR Dermatol
September 2024
Department of Dermatology, University of Colorado School of Medicine, Aurora, CO, United States.
Article Synopsis
- In 2023, JMIR Dermatology expanded its scope to include research on all aspects of skin, hair, and nail diseases, while acknowledging the contributions of reviewers, staff, and authors.
- The journal introduced a new Research Letter format and an In Memorium article type to honor distinguished figures in the field of dermatology.
- Additionally, the editorial highlights the top three publications from 2023 based on Altmetric scores and outlines future plans for the journal.
Disintegration at the Syntax-Semantics Interface in Prodromal Alzheimer's Disease: New Evidence from Complex Sentence Anaphora in Amnestic Mild Cognitive Impairment (aMCI).
J Neurolinguistics
May 2024
Department of Psychiatry, Massachusetts General Hospital.
Although diverse language deficits have been widely observed in prodromal Alzheimer's disease (AD), the underlying nature of such deficits and their explanation remains opaque. Consequently, both clinical applications and brain-language models are not well-defined. In this paper we report results from two experiments which test language production in a group of individuals with amnestic Mild Cognitive Impairment (aMCI) in contrast to healthy aging and healthy young.
View Article and Find Full Text PDFArticle Synopsis
- A study was conducted on 66 elderly patients with Takayasu's arteritis (TAK) to assess how disease progression and treatment outcomes vary with age.
- Patients were categorized into four age groups, revealing that as age increased, the duration of the disease was longer, and there was a decrease in the use of prednisone and immunosuppressive drugs.
- Results indicated that older patients had a greater impairment in functional status, suggesting that this decline may be related to factors associated with aging rather than the disease itself.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!